The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

WST FINANCIAL STATEMENTS

West Pharmaceutical Services Inc — balance sheet, income statement and cash flow trends

WSTWest Pharmaceutical Services Inc

🇺🇸 USA · US · Healthcare · Medical Instruments & Supplies

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
01 B2 B3 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue3.3 B $Gross Profit1.2 B $ · 37%Operating Income686.5 M $ · 21%Pre-tax Income699.6 M $ · 21%Net Income to Owners564.9 M $ · 17%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue3.3 B $+12.4%
Gross Profit1.2 B $+17.0%
Operating Income686.5 M $+9.8%
EBITDA824.2 M $+8.4%
Net Income to Owners564.9 M $+15.8%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets4.1 B
  • Equity3 B $73%
  • Current Liabilities640.5 M $16%
  • Long-term Liabilities445.7 M $11%

Key Figures

YoY change
Total Assets4.1 B $+3.1%
Total Liabilities1.1 B $+6.1%
Total Equity3 B $+2.1%
Cash & ST Investments435.8 M $-14.5%
Total Debt312.1 M $+2.9%
Net Debt-123.7 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0250 M500 M750 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0200 M400 M600 M662.2 M $Operating-225.3 M $Investing-496.7 M $Financing-59.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow662.2 M $-2.1%
Capital Expenditures225.3 M $-32.3%
Free Cash Flow436.9 M $+27.0%
Dividends Paid62.4 M $+3.8%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on WST

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.